Cargando…

Lung metastases from intraductal papillary neoplasm of the bile duct: a case report

BACKGROUND: Intraductal papillary neoplasm of the bile duct (IPNB) is considered a pre-cancerous biliary lesion and/or an early cancer lesion, although its classification remains unclear. The 2019 revised edition of the World Health Organization Classification of Tumors of the Digestive System propo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujino, Rika, Masuoka, Yoshihito, Mashiko, Taro, Nakano, Akira, Hirabayashi, Kenichi, Nakagohri, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585296/
https://www.ncbi.nlm.nih.gov/pubmed/33097064
http://dx.doi.org/10.1186/s12957-020-02054-9
_version_ 1783599759093661696
author Fujino, Rika
Masuoka, Yoshihito
Mashiko, Taro
Nakano, Akira
Hirabayashi, Kenichi
Nakagohri, Toshio
author_facet Fujino, Rika
Masuoka, Yoshihito
Mashiko, Taro
Nakano, Akira
Hirabayashi, Kenichi
Nakagohri, Toshio
author_sort Fujino, Rika
collection PubMed
description BACKGROUND: Intraductal papillary neoplasm of the bile duct (IPNB) is considered a pre-cancerous biliary lesion and/or an early cancer lesion, although its classification remains unclear. The 2019 revised edition of the World Health Organization Classification of Tumors of the Digestive System proposed type 1 and type 2 as new classification categories, and meta-analyses and/or multi-center cohort studies are beginning to be reported. However, treatment for IPNB recurrence and metastasis remains unclear. CASE PRESENTATION: A 60-year-old man who was referred to our hospital after a suspected liver tumor was diagnosed using abdominal ultrasonography. Imaging findings revealed an irregularly shaped tumor in segment 5 (S5) of the liver (size 20 mm). The S5 lesion was suspected as IPNB, and segmentectomy was performed. The pathological findings revealed invasive carcinoma derived from IPNB, and immunohistochemistry revealed positive expression of MUC1, MUC5AC, and MUC6, but negative expression of CDX2 and MUC2. At 9 months after the surgery, computed tomography revealed a tumor in the right bile duct, which was diagnosed as liver recurrence of IPNB, and right hepatectomy was performed. The histopathological findings were the same as for the first resected specimen (i.e., IPNB). At 45 months after the second surgery, computed tomography revealed nodules in both lungs, which were diagnosed as lung metastases from IPNB and resected in two separate procedures. The pathological findings were metastatic carcinoma from IPNB for both lung lesions. The patient is currently alive and undergoing adjuvant chemotherapy (S-1), which was initiated 64 months after the first resection and 12 months after resection of the lung metastases. CONCLUSION: We encountered a rare case of lung metastases from IPNB, which were diagnosed immunohistologically. Because IPNB is generally a slow-growing tumor, resection may be feasible for IPNB recurrence and/or metastasis, which may be detected during long-term follow-up. Thus, even if resection is performed for primary IPNB, additional surgical treatment may be feasible in this setting.
format Online
Article
Text
id pubmed-7585296
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75852962020-10-26 Lung metastases from intraductal papillary neoplasm of the bile duct: a case report Fujino, Rika Masuoka, Yoshihito Mashiko, Taro Nakano, Akira Hirabayashi, Kenichi Nakagohri, Toshio World J Surg Oncol Case Report BACKGROUND: Intraductal papillary neoplasm of the bile duct (IPNB) is considered a pre-cancerous biliary lesion and/or an early cancer lesion, although its classification remains unclear. The 2019 revised edition of the World Health Organization Classification of Tumors of the Digestive System proposed type 1 and type 2 as new classification categories, and meta-analyses and/or multi-center cohort studies are beginning to be reported. However, treatment for IPNB recurrence and metastasis remains unclear. CASE PRESENTATION: A 60-year-old man who was referred to our hospital after a suspected liver tumor was diagnosed using abdominal ultrasonography. Imaging findings revealed an irregularly shaped tumor in segment 5 (S5) of the liver (size 20 mm). The S5 lesion was suspected as IPNB, and segmentectomy was performed. The pathological findings revealed invasive carcinoma derived from IPNB, and immunohistochemistry revealed positive expression of MUC1, MUC5AC, and MUC6, but negative expression of CDX2 and MUC2. At 9 months after the surgery, computed tomography revealed a tumor in the right bile duct, which was diagnosed as liver recurrence of IPNB, and right hepatectomy was performed. The histopathological findings were the same as for the first resected specimen (i.e., IPNB). At 45 months after the second surgery, computed tomography revealed nodules in both lungs, which were diagnosed as lung metastases from IPNB and resected in two separate procedures. The pathological findings were metastatic carcinoma from IPNB for both lung lesions. The patient is currently alive and undergoing adjuvant chemotherapy (S-1), which was initiated 64 months after the first resection and 12 months after resection of the lung metastases. CONCLUSION: We encountered a rare case of lung metastases from IPNB, which were diagnosed immunohistologically. Because IPNB is generally a slow-growing tumor, resection may be feasible for IPNB recurrence and/or metastasis, which may be detected during long-term follow-up. Thus, even if resection is performed for primary IPNB, additional surgical treatment may be feasible in this setting. BioMed Central 2020-10-23 /pmc/articles/PMC7585296/ /pubmed/33097064 http://dx.doi.org/10.1186/s12957-020-02054-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Fujino, Rika
Masuoka, Yoshihito
Mashiko, Taro
Nakano, Akira
Hirabayashi, Kenichi
Nakagohri, Toshio
Lung metastases from intraductal papillary neoplasm of the bile duct: a case report
title Lung metastases from intraductal papillary neoplasm of the bile duct: a case report
title_full Lung metastases from intraductal papillary neoplasm of the bile duct: a case report
title_fullStr Lung metastases from intraductal papillary neoplasm of the bile duct: a case report
title_full_unstemmed Lung metastases from intraductal papillary neoplasm of the bile duct: a case report
title_short Lung metastases from intraductal papillary neoplasm of the bile duct: a case report
title_sort lung metastases from intraductal papillary neoplasm of the bile duct: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585296/
https://www.ncbi.nlm.nih.gov/pubmed/33097064
http://dx.doi.org/10.1186/s12957-020-02054-9
work_keys_str_mv AT fujinorika lungmetastasesfromintraductalpapillaryneoplasmofthebileductacasereport
AT masuokayoshihito lungmetastasesfromintraductalpapillaryneoplasmofthebileductacasereport
AT mashikotaro lungmetastasesfromintraductalpapillaryneoplasmofthebileductacasereport
AT nakanoakira lungmetastasesfromintraductalpapillaryneoplasmofthebileductacasereport
AT hirabayashikenichi lungmetastasesfromintraductalpapillaryneoplasmofthebileductacasereport
AT nakagohritoshio lungmetastasesfromintraductalpapillaryneoplasmofthebileductacasereport